Motilal Oswal’s recent analysis of Max Healthcare Institute Ltd (MAXH) suggests a promising growth trajectory backed by robust revenue generation and strategic expansions across multiple healthcare
Anand Rathi Research has upgraded Narayana Hrudayalaya to a BUY rating with a revised target price of Rs 1,550, offering a potential upside of approximately 30% from its current price of Rs 1,196.
ICICI Direct has recommended a BUY rating on Narayana Hrudayalaya (NARHRU), a leading chain of multi-specialty hospitals, with a target price of Rs 1,485, representing a potential upside of 22% fro
Fortis Healthcare Ltd has announced that its board has approved the issuance of non-convertible debentures (NCDs) worth Rs 1,500 crore via private placement.